Site icon European Science-Media Hub

12 Covid-19 vaccines to watch

Ampoules with Covid-19 vaccine on a laboratory bench to fight the coronavirus sars-cov-2 pandemic

A range of Covid-19 vaccines are being developed worldwide. Which ones are authorised and assessed in the EU? Which are still in development? Check our table below.

Company Type Efficacy* Doses Storage Status in Europe* Secured by EU

Pfizer / BioNTech

mRNA*
600 mn
Moderna
mRNA
-20°C
460 mn
AstraZeneca / Oxford
Adenovirus-vectored technology*
Fridge
400 mn
Johnson&Johnson / Janssen
Adenovirus-vectored technology
Fridge
400 mn
Novavax
Protein
Fridge
~200 mn
CVnCoV - CureVac AG
mRNA
Fridge
405 mn
Sputnik V - Gamaleya Research Institute
Adenovirus-vectored technology
-18°C

Rolling review
Emergency use in Hungary, BiH, Serbia, Montenegro

CoronaVac - Sinovac
Inactivated virus
Fridge

Rolling review
Emergency use in Turkey

BBIBP-CorV - Sinopharm
Inactivated virus
Fridge
Emergency use in Hungary, Serbia
VLA2001 - Valneva
Inactivated virus
Fridge

In development

~60 mn

Sanofi & GSK (x2 vaccines)

mRNA & protein

Rolling review of Vidprevtyn
(protein-based vaccine)

300 mn

• Efficacy: numbers vary in different sources
mRNA: messenger RNA, part of the virus’ genetic code
Adenovirus-vectored technology: genetically modified cold virus
• Status in Europe: overview of the situation in EU and in the candidates/potential candidates countries.

Sources: WHO, EMA, EC, Astrazeneca, Sanofi, JnJ, Novavax, SputnikVaccine, TheLancet, Nature & other.

Last update : 20 July 2021

Exit mobile version